|
The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases.
|
Écrit par Oana |
Clics : 112
|
|
Sample Pooling and Inflammation Linked to the False Selection of Biomarkers for Neurodegenerative Diseases in Top-Down Proteomics: A Pilot Study
|
Écrit par Oana |
Clics : 108
|
|
NEDDylation promotes nuclear protein aggregation and protects the Ubiquitin Proteasome System upon proteotoxic stress
|
Écrit par Oana |
Clics : 102
|
|
Computational B-cell epitope identification and production of neutralizing murine antibodies against Atroxlysin-I
|
Écrit par Oana |
Clics : 103
|
|
SNAP23-Kif5 complex controls mGlu1 receptor trafficking
|
Écrit par Oana |
Clics : 114
|
|
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
|
Écrit par Oana |
Clics : 103
|
|
Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer
|
Écrit par Oana |
Clics : 105
|
|
Impact of biological matrix on inflammatory protein biomarker quantification based on targeted mass spectrometry
|
Écrit par Oana |
Clics : 105
|
|
Alzheimer's Disease: Advances in Drug Development
|
Écrit par Oana |
Clics : 124
|
|
Regulatory context and validation of assays for clinical mass spectrometry proteomics (cMSP) methods.
|
Écrit par Oana |
Clics : 109
|
